To increase monkeypox testing capacity during the U.S. outbreak, the Centers for Disease Control and Prevention yesterday began shipping orthopoxvirus tests to five commercial laboratory companies: Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare. The laboratories should be available to health care providers by early July, with capacity increasing throughout the month, CDC said. Testing capacity through CDC’s Laboratory Response Network also has increased to over 8,000 tests per week since the first U.S. monkeypox case was reported in May, the agency said.  

 
CDC encourages clinicians to consider testing all suspect rashes for monkeypox. The Food and Drug Administration is exercising enforcement discretion regarding CDC’s tests, which permits hospitals to develop their own laboratory developed tests. CDC has published an FDA-approved testing protocol for any laboratory interested in testing for monkeypox, and yesterday updated its guidance on specimen collection. Only certain laboratory personnel using specified safety protocols should perform culture-based testing for monekypox. As of June 21, 142 U.S. monkeypox cases have been reported.  
 

Related News Articles

Headline
As the number of U.S. monkeypox cases continues to grow, Health and Human Services Secretary Xavier Becerra today declared the outbreak a public health…
Headline
President Biden yesterday named Federal Emergency Management Agency Region 9 Administrator Robert Fenton to coordinate the administration’s monkeypox response…
Headline
Inpatient and outpatient prospective payment system hospitals, inpatient psychiatric facilities and PPS-exempt cancer hospitals have until Aug. 30 to preview…
Headline
The Department of Health and Human Services has secured an additional 786,000 doses of JYNNEOS monkeypox vaccine, which officials said states can begin…
Headline
World Health Organization Director-General Tedros Adhanom Ghebreyesus Saturday declared monkeypox a public health emergency of international concern and…
Headline
The Centers for Disease Control and Prevention last night endorsed the two-dose Novavax COVID-19 vaccine as a COVID-19 vaccine primary series for…